The bond market is boosting its bets on a Federal Reserve interest-rate increase in June as stocks and oil rally.
After Treasury 10-year notes recorded a third straight weekly decline, traders now see the odds of a June rate hike at about a coin flip, according to futures data compiled by Bloomberg.
That’s up from a 45% chance assigned March 10 and odds below 10% seen a month ago. Since 1994, the Fed hasn’t raised rates unless the futures market had priced in at least 60% of the move the day before, Bank of America interest-rate strategist Mark Cabana wrote in a March 11 note.
“It seems like the market is within in the range” that “the Fed would be comfortable with” for a June increase, Cabana said by phone from New York.
There’s almost no market expectation for the Fed to raise rates at its next policy-setting meeting on March 15-16, with the futures market implying a 4% chance, assuming the fed funds effective rate averages 0.625% after the next hike.
For the central bank’s June meeting, though, the market-implied probability rose to 50% on Friday as gains in stocks and crude prices dented demand for Treasuries and other havens.
Benchmark 10-year note yields rose 11 basis points last week, or 0.11 percentage point, to 1.98% as of 5 pm New York time on Friday, according to Bloomberg Bond Trader data, the highest on a closing basis since January 27.
The price of the 1.625% security due in February 2026 fell 31/32, or $9.69 per $1,000 face amount, to 96 25/32.
An equities rally on Friday helped the Bloomberg US Financial Conditions Index, which tracks financial-market stress, turn positive for the first time this year.
The Bank of America analysts found that the amount of Fed tightening has been “closely linked” to financial conditions since the start of 2015, and the market seems to have noticed.
On February 11, the 2016 low for stocks, Treasury yields and the Bloomberg Financial Conditions Index, the futures-implied probability of a Fed hike this year was 11%. By Friday, the probability had climbed to 77%.
That might eventually pose a challenge for both traders and US central-bank officials, said Cabana. “At some point, they’re going to want to break that link, and that could be a surprise to the market and put them in a bit of a tight spot,” he said.
Improving US economic data in recent weeks have boosted the outlook for inflation and economic growth. Citigroup’s Economic Surprise Index for the US, which measures the strength of data relative to analysts’ forecasts, climbed to minus 9.3 on Friday, the highest closing level since November.
While still below zero, which shows data releases have been undershooting predictions, the gauge has risen from an eight- month low of minus 55.7 reached on February 4.
As data and financial conditions improve, Treasuries have been the worst performers after Canadian bonds in the past month among global sovereign debt, based on Bloomberg World Bond Indexes, which track 26 nations. US debt has lost 1.2%, and Canadian debt has handed investors a 1.7% loss.
Even so, more losses could be in store, according to Mark Kiesel, chief investment officer for global credit at Pacific Investment Management Co. He said the market is still underrating US economic strength and the Fed’s path.
“The market may be underestimating the fact that the US economy is doing pretty well, and that the Fed is probably going to go this year,” he said in an interview on Bloomberg Television on Friday.
The US will sell $11bn in 10-year Treasury Inflation-Protected Securities on March 17.
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
Tencent loses $51bn in market value in 2 days
Nissan sees EV sales surging to 1mn annually by 2022
$60bn CPEC boosts Pakistan’s economy
BoJ deputy governor says price gains insufficient, wants stronger policy regime
WTO chief warns trade barriers will ‘jeopardise the global economy’
US core capital goods orders, shipments jump in February
Trade war fears knock Europe markets down
China threatens US with tariffs, says ‘not afraid of trade war’
GSK pulls out of $20bn race for Pfizer consumer assets